i&i Biotech Fund
Venture capitalPrague · Seed–Series B · 4 people tracked
Investment thesis
i&i Biotech Fund is a Luxembourg-based venture capital firm investing in European life science companies developing pharmaceuticals, medical devices, diagnostics, and digital health solutions.
Team · 4 people
from the firm's websiteFrequently asked questions
- What stage does i&i Biotech Fund invest at?
- i&i Biotech Fund invests at the Seed, Series A, Series B stages.
- What is i&i Biotech Fund's typical check size?
- i&i Biotech Fund typically writes checks of $162K – $2.2M.
- What sectors does i&i Biotech Fund focus on?
- i&i Biotech Fund focuses on Biotech, Healthtech, Medical Devices.
- Where is i&i Biotech Fund located?
- i&i Biotech Fund is headquartered in Prague, CZ.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.